RecruitingPhase 4NCT03734900

Comparison of Effectiveness Between PL and PRP on Knee Osteoarthritis: a Prospective,Randomized,Placebo-controlled Trial

Comparison of Effectiveness Between Platelet Lysate and Platelet-rich Plasma on Knee Osteoarthritis: a Prospective, Randomized, Placebo-controlled Trial


Sponsor

National Taiwan University Hospital

Enrollment

150 participants

Start Date

May 15, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

This study will focus on grade I to III knee osteoarthritis by randomized controlled trials which comparing the effectiveness between placebo, autologous platelet rich plasma and autologous platelet lysate injections.


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called PL injection, a biological treatment called PRP injection, and others for people with osteoarthritis(oa) of the knee. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSaline injection

5ml Placebo infusion of 0.9% Sodium Chloride

BIOLOGICALPRP injection

Device: "Aeon" Acti-PRP 5ml autologous platelet rich plasma injection

BIOLOGICALPL injection

Device: "Aeon" Acti-PRP 5ml autologous platelet lysate injection


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03734900


Related Trials